Cargando…
Phase III randomised chemoprevention study of Selenium on the recurrence of non-invasive bladder cancer. The SELEnium and BLAdder cancer Trial (SELEBLAT)
Autores principales: | Goossens, Maria (Mieke), Zeegers, Maurice, Van Poppel, Hendrik, Joniau, Steven, Ackaert, Koen, Ameye, Filip, Billiet, Ignace, Dillen, Kurt, Goeman, Lieven, Van Bruwaene, Siska, Van der Aa, Frank, Vekemans, Kris, Buntinx, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582342/ http://dx.doi.org/10.1186/2049-3258-73-S1-P5 |
Ejemplares similares
-
Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium
por: Goossens, Maria E, et al.
Publicado: (2012) -
Selenium and risk of bladder cancer
por: Złowocka-Perłowska, E, et al.
Publicado: (2012) -
Risk of bladder cancer in patients with diabetes: a retrospective cohort study
por: Goossens, Maria (Mieke), et al.
Publicado: (2015) -
Influence of metformin intake on the risk of bladder cancer in type 2 diabetes patients
por: Goossens, Maria (Mieke), et al.
Publicado: (2015) -
Development of a Prospective Data Registry System for Non-muscle-Invasive Bladder Cancer Patients Incorporated in the Electronic Patient File System
por: Akand, Murat, et al.
Publicado: (2019)